Iopamidol Injection

IopamidolInjection is the second-generation non-ionic iodinated Contrast Media launched in the global market. In 2015, Beilu firstly launched and listed iopamiro injectionin the Chinese market. If you want to know iopamidol cost, please contact us.

Product name: Iopamidol Injectionnon

Generic name: Iopamidol Injection

Type: Injectable Contrast Media for CT/X-ray

Ingredients: iopamidol 300, iopamidol 370

Specification:

(1) 50ml: 15 gl

(2) 100ml: 30 gl

(3) 50ml: 18.5 gl

(4) 100ml: 37 gl

Administration: Intravascular injection

Adverse reactions: The application of organic iodine compounds can cause adverse reactions, as well as allergic or drug-induced shock. See the details from the package insert

Shelf life: 36 months

Advantages of Iopamidol Injection

High enhancement value, which increased the contrast between the lesion and solid organs, improved the lesion detection.

Low viscosity

Low osmotic pressure

Low injection speed, which reduces vascular pressure and prevents contrast media extravasation (patient with poor tolerance, such as children, elderly, diabetes or tumor patients, are more suitable for high-concentration contrast media)

The low total dosage of Contrast media

Low radiation dose

Indications of Iopamidol Injection

Neuroradiology: Spinal nerve root angiography, Cisternography and ventriculography.

Angiography: Cerebral arteriography, Coronary angiography, Thoracic aorta and abdominal aorta angiography, Angiocardiography, Selectivevisceral arteriography, Peripheral arteriography and venography, Digital subtraction angiography of cerebral arteries, peripheral arteries and abdominal arteries.

Urinary system angiography: Venous urography, Enhanced scan in CT examination, Arthrography, Fistula angiography, Digital subtraction angiography.

Precautions please refer to the package insert.

Founded in 1992, Beilu Pharmaceuticalis mainly engaged in the research & development, production and sales of pharmaceutical products. It is high-tech innovation company with core competence in the Contrast Media domestic. Beilu provides complete gadolinium contrast mediaproducts suitable for X-Ray and Magnetic Resonance Imaging (MRI), and it is the leading manufacturer in the Contrast Media field in China.

Другие товары поставщика

	Repaglinide Tablets	Repaglinide tabletsare non-sulfonylurea insulin secretion agents and are used to treat patients with type 2 diabetes. Repaglinide tablets were list...
	Contrast Media Manufacturing Company	For the purpose of medical imaging, a certain substance is introduced into the human body to change the image contrast of local tissues of the body...
	Gadopentetate Dimeglumine Injection/API	Founded in 1992, BeijingBeiluPharmaceuticalsCompanyLimitedis mainly engaged in the research & development, production and sales of pharmaceutic...
	Glimepiride Tablets	Glimepiride Tablets is a sulfonylurea hypoglycemic drug that can be used in combination with insulin. In 2001, Glimepiride tablets (Dibei), as the ...
	Diethylenetriaminepentaacetic acid (DTPA)	DTPA Diethylenetriaminepentaacetic Acid(DTPA) CAS No.: 67-43-6 Molecular formula: C₁₄H₂₃N₃O₁₀ Molecular weight: 393.35 Quality standard...

Все товары поставщика

Похожие товары

	Calcobutrol	Продавец: Beijing Beilu Pharmaceutical Co., Ltd	Calcobutrol CAS No.: Molecular formula: C18H32CaN4O9 Molecular weight: 488.5461 Qual...
	Repaglinide Tablets	Продавец: Beijing Beilu Pharmaceutical Co., Ltd	Repaglinide tabletsare non-sulfonylurea insulin secretion agents and are used to treat patients w...
	MRI Contrast Media	Продавец: Beijing Beilu Pharmaceutical Co., Ltd	agnetic resonance imaging Contrast Media (MRI Contrast Media), also called Magnetic resonance ima...
	Iopamidol Injection	Продавец: Beijing Beilu Pharmaceutical Co., Ltd	IopamidolInjection is the second-generation non-ionic iodinated Contrast Media launched in the gl...
	Iohexol Injection	Продавец: Beijing Beilu Pharmaceutical Co., Ltd	Iohexol Injection is a non-ionic Contrast Media. Compared with a traditional ionic Contrast Media...